Improvement of bowel dysfunction with sacral neuromodulation for refractory urge urinary incontinence

Gill, Bradley C.; Swartz, Mia A.; Rackley, Raymond R.; Moore, Courtenay; Goldman, Howard B.; Vasavada, Sandip P.

doi:10.1007/s00192-011-1553-6

Cited by 13 publications

(12 citation statements)

References 32 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A recent study showed improvement of bowel dysfunction in patients implanted with SNM for urinary urgency incontinence. There was significant improvement in mean urinary and bowel symptom scores, though only urinary quality of life (QOL) scores improved …”

Section: Fecal Incontinence (Fi)mentioning

confidence: 99%

“…Similarly, for FI, where limited therapies exist beyond pelvic‐floor therapy and modification of stool consistency, patients should be alerted that SNM therapy exists . Patients with dual bladder and bowel disorders stand to benefit with respect to both symptoms, which may direct the clinician to educate the patient about SNM almost at the first encounter. This is discussed in further detail elsewhere in this consensus statement.…”

Section: Tips For Introduction Of Snm To Patientsmentioning

confidence: 99%

See 1 more Smart Citation

International Continence Society best practice statement for use of sacral neuromodulation

Goldman

Lloyd

Noblett

et al. 2018

Neurourology and Urodynamics

Self Cite

138

View full text Add to dashboard Cite

show abstract

Section: Fecal Incontinence (Fi)mentioning

confidence: 99%

Section: Tips For Introduction Of Snm To Patientsmentioning

confidence: 99%

International Continence Society best practice statement for use of sacral neuromodulation

Goldman

Lloyd

Noblett

et al. 2018

Neurourology and Urodynamics

Self Cite

138

View full text Add to dashboard Cite

show abstract

“… SNS may be indicated for a patient with FI and urinary symptoms. Such patients should be discussed with a urologist . …”

Section: Consensusmentioning

confidence: 99%

“…• SNS may be indicated for a patient with FI and urinary symptoms. Such patients should be discussed with a urologist [113][114][115][116][117][118][119]. (Abstained 0, voted 22.…”

Section: Sns For Concomitant Urinary Symptomsmentioning

confidence: 99%

Sacral nerve stimulation for faecal incontinence and constipation: a European consensus statement

et al. 2015

View full text Add to dashboard Cite

show abstract

“…After careful evaluation of full‐text papers 27 studies were excluded: 15 studies 23–37 did not evaluate FI assessment, six manuscripts 38–43 were just protocols, five were paediatric studies, 44–48 and one trial 49 had an inappropriate study design. Finally, 328 studies were included in our review: 306 studies…”

Section: Resultsmentioning

confidence: 99%

Tools for fecal incontinence assessment: lessons for inflammatory bowel disease trials based on a systematic review

et al. 2020

View full text Add to dashboard Cite

Background Fecal incontinence is a disabling condition affecting up to 20% of women. Objective We investigated fecal incontinence assessment in both inflammatory bowel disease and non-inflammatory bowel disease patients to propose a diagnostic approach for inflammatory bowel disease trials. Methods We searched on Pubmed, Embase and Cochrane Library for all studies on adult inflammatory bowel disease and non-inflammatory bowel disease patients reporting data on fecal incontinence assessment from January 2009 to December 2019. Results In total, 328 studies were included; 306 studies enrolled non-inflammatory bowel disease patients and 22 studies enrolled inflammatory bowel disease patients. In non-inflammatory bowel disease trials the most used tools were the Wexner score, fecal incontinence quality of life questionnaire, Vaizey score and fecal incontinence severity index (in 187, 91, 62 and 33 studies). Anal manometry was adopted in 41.2% and endoanal ultrasonography in 34.0% of the studies. In 142 studies (46.4%) fecal incontinence evaluation was performed with a single instrument, while in 64 (20.9%) and 100 (32.7%) studies two or more instruments were used. In inflammatory bowel disease studies the Wexner score, Vaizey score and inflammatory bowel disease quality of life questionnaire were the most commonly adopted tools (in five (22.7%), five (22.7%) and four (18.2%) studies). Anal manometry and endoanal ultrasonography were performed in 45.4% and 18.2% of the studies. Conclusion Based on prior validation and experience, we propose to use the Wexner score as the first step for fecal incontinence assessment in inflammatory bowel disease trials. Anal manometry and/or endoanal ultrasonography should be taken into account in the case of positive questionnaires.

show abstract

Improvement of bowel dysfunction with sacral neuromodulation for refractory urge urinary incontinence

Abstract: Bowel dysfunction is common in women with refractory UUI. SNS improves urinary symptoms and QOL, but improvement in bowel symptoms does not translate into significant QOL changes.

Cited by 13 publications

References 32 publications

International Continence Society best practice statement for use of sacral neuromodulation

International Continence Society best practice statement for use of sacral neuromodulation

Sacral nerve stimulation for faecal incontinence and constipation: a European consensus statement

Tools for fecal incontinence assessment: lessons for inflammatory bowel disease trials based on a systematic review

Contact Info

Product

Resources

About